Inspection Record

B Positive National Blood Services - Wyoming, LLC. — FDA 483 Findings

US FDAInspected 2026-02-02Published 2026-07-24 3 findingsOther quality systemMaterial and supplier control

Inspectors Michele GottshallThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Failure to use supplies and reagents in a manner consistent with instructions provided by the manufacturer.

2Other quality system

Records are not made concurrently with the performance of each step in the distribution of products.

3Material and supplier control

Written standard operating procedures including all steps to be followed in the collection, processing, storage and distribution ofblood and blood components for further manufacturing purposes were not always established.

About this record

Extracted automatically from the document US FDA published on 2026-07-24. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

B Positive National Blood Services - Wyoming, LLC. company profile — full history US FDA documents, 2026 Go to Findings search